跳至主要内容
临床试验/JPRN-UMIN000018138
JPRN-UMIN000018138已完成2 期

A phase II trial of induction CDDP plus TS-1 with concurrent radiotherapy followed by surgical resection in patients with resectable stage IIIA-N2 non-small cell lung cancer - A phase II trial of induction chemoradiotherapy followed by surgery in patients with resectable stage IIIA-N2 NSCLC

Gunma University Hospital0 个研究点目标入组 30 人开始时间: 2015年6月30日最近更新:

试验速览

阶段
2 期
状态
已完成
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 75years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1)History of active infection 2)Severe diarrhea 3)Severe complication (Severe GI disease, bowel obstruction, interstitial pneumonia or pulmonary fibrosis detectable on chest Xp, uncontrollable diabetes mellitus, history of severe heart disease, severe renal disease, severe hepatic disease, Current history of GI ulcer, Current history of myocardial infarction and angina pectoris) 4)Autoimmune disease requiring immunosuppressive agent 5)History of active double cancer 6)History of pregnancy or lactation 7)History of psychiatric disorder 8)Systemic administration of steroid 9)Severe drug allergy 10) Hepatitis Bc antibody or hepatitis Bs antigen positive 11)Administration of flucytosine 12)Investigational new drug or the unapproved drug is administered 13)Any other medical condition that makes the patient unsuitable for inclusion in the study according to the opinion of the investigator

研究者

相似试验